GlassScriptPhysician profile
Edgar Fincher
NPI 1083661359
$3,674.56
in general payments reported to CMS, 2019-2025
34 companies · $621 in 2025
The $621 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $340 · 2020: $343 · 2021: $308 · 2022: $329 · 2023: $511 · 2024: $1,222 · 2025: $621.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,354.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $463.65 | 2022-2025 | Sotyktu |
| Abbvie INC. | $371.47 | 2023-2025 | |
| Pfizer INC. | $357.12 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $318.70 | 2021-2025 | Libtayo |
| Sun Pharmaceutical Industries INC. | $292.05 | 2020-2025 | Blu-U, Odomzo |
| Organogenesis INC. | $211.10 | 2021-2025 | Cygnus Dual |
| Galderma Laboratories, L.P. | $200.35 | 2019-2025 | Nemluvio, Dysport |
| Strata Skin Sciences, INC. | $190.82 | 2022-2025 | Xtrac |
| Smith+Nephew, INC. | $159.35 | 2022-2025 | Grafix Pl, Grafix Xc, Oasis Micro |
| Leo Pharma INC. | $114.05 | 2019-2025 | Adbry, Anzupgo |
| Almirall LLC | $109.35 | 2021-2024 | Klisyri, Seysara |
| Kyowa Kirin, INC. | $88.25 | 2022-2023 | Poteligeo |
| Incyte Corporation | $81.45 | 2023-2025 | Opzelura |
| Revance Therapeutics, INC. | $78.20 | 2024 | Daxxify |
| Merz North America, INC. | $77.00 | 2019-2023 | Xeomin |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $65.49 | 2020-2024 | Otezla |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $61.03 | 2019-2024 | Jublia, Cabtreo, Arazlo |
| Bioventus LLC | $59.94 | 2022 | |
| Mimedx Group, INC. | $37.19 | 2024 | |
| Arcutis Biotherapeutics, INC. | $35.55 | 2023-2024 | Zoryve |
| Mayne Pharma Commercial LLC | $34.54 | 2019-2022 | |
| Polarityte, INC. | $30.33 | 2020 | |
| Krystal Biotech INC | $26.11 | 2023 | Vyjuvek |
| Pacira Pharmaceuticals Incorporated | $25.45 | 2024 | Exparel |
| Mindera Corp | $23.77 | 2025 | |
| Solta Medical, A Division of Bausch Health US, LLC | $22.95 | 2024 | Clear & Brilliant |
| Lnhc, INC | $20.70 | 2025 | Zelsuvmi |
| Oxford Immunotec USA INC | $19.72 | 2021 | |
| Janssen Biotech, INC. | $18.50 | 2022 | |
| Biofrontera INC. | $17.60 | 2019 | |
| Vyne Pharmaceuticals INC. | $17.26 | 2020 | |
| Aclaris Therapeutics, INC. | $15.81 | 2019 | |
| Mission Pharmacal Company | $15.79 | 2019 | |
| Merck Sharp & Dohme LLC | $13.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edgar Fincher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.